These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6464609)

  • 21. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenobarbital for treatment of seizures in preterm infant: a new administration scheme.
    De Carolis MP; Muzii U; Romagnoli C; Zuppa AA; Zecca E; Tortorolo G
    Dev Pharmacol Ther; 1989; 14(2):84-9. PubMed ID: 2630236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
    Whyte MP; Dekaban AS
    Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Frequency analysis of the human EEG in relation to the blood level of phenobarbital].
    Sannita W; Cupello A; Ferrillo F; Lazzarini G; Rosadini G
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):192-6. PubMed ID: 4779763
    [No Abstract]   [Full Text] [Related]  

  • 25. Eterobarb therapy in epilepsy.
    Mattson RH; Williamson PD; Hanahan E
    Neurology; 1976 Nov; 26(11):1014-7. PubMed ID: 824567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
    Bethmann K; Brandt C; Löscher W
    Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum phenobarbitone estimation in epilepsy.
    Shukla R; Agarwal SK; Nag D; Gupta NN; Kar AM
    J Assoc Physicians India; 1982 Aug; 30(8):505-7. PubMed ID: 7169485
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticonvulsant drug-serum levels in psychiatric patients with seizure disorders. Effects of certain psychotropic drugs.
    Siris JH; Pippenger CE; Werner WL; Masland RL
    N Y State J Med; 1974 Aug; 74(9):1554-6. PubMed ID: 4527066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Polytherapy and monotherapy in the treatment of epileptic patients].
    Petrone F; Cavalcanti S; Turchiaro GG; Rolando G
    Acta Neurol (Napoli); 1981 Feb; 3(1):76-84. PubMed ID: 7246321
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug resistant epilepsy in Senegal: therapeutic, clinical and socioeconomic factors].
    Gueye L; Sene MC; Sene F; Mesdjian E; Farnarier G; Diagne M; Ndiaye IP
    Dakar Med; 1999; 44(1):1-7. PubMed ID: 10797976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with phenobarbital and monitoring of epileptic patients in rural Mali.
    Nimaga K; Desplats D; Doumbo O; Farnarier G
    Bull World Health Organ; 2002; 80(7):532-7. PubMed ID: 12163916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.
    Brandt C; Volk HA; Löscher W
    Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenobarbital and diphenylhydantoin in the plasma and phenobarbital in the cerebrospinal fluid. II. Relationship between the determination of phenobarbital in the spinal fluid and phenobarbital in the plasma].
    Isumi N
    Nihon Shonika Gakkai Zasshi; 1970 May; 74(5):552-7. PubMed ID: 5464712
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
    Ermani M; Giaretta D; Pellegrini A; Chemello R; Testa G
    Riv Neurol; 1983; 53(2):81-93. PubMed ID: 6879058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
    Muraoka K
    No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of dose-plasma concentration relationship of phenobarbital in epileptic patients by a new specific radioimmunoassay.
    Kawashima K; Ishijima B; Yoshimizu N; Sato F
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):166-76. PubMed ID: 7416885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PB:PRM ratio in patients with epilepsy treated with primidone.
    Cornaggia CM; Altamura AC; Bianchi M; Canger R; Polana P; Pruneri C
    Int J Clin Pharmacol Res; 1983; 3(3):185-93. PubMed ID: 6679521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenobarbital prophylaxis of post traumatic epilepsy.
    Murri L; Parenti G; Bonuccelli U; Lenzi B; Del Tacca M
    Ital J Neurol Sci; 1980 Oct; 1(4):225-30. PubMed ID: 6802779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.